Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Impact of Renal Impairment on the Pharmacokinetic and Pharmacodynamic of LEO 27847

NCT01141179 is registered in ClinicalTrials.gov with LEO Pharma as lead sponsor.

NCT NCT01141179
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01141179 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Impact of Renal Impairment on the Pharmacokinetic and Pharmacodynamic of LEO 27847
Lead sponsor
LEO Pharma
Phase
Phase 1
Overall status
Completed
Start date
May 31, 2010
Completion date
February 28, 2011
Enrollment
25 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

renal impairment